The deal will boost Boston Scientific’s electrophysiology and structural heart product portfolios.
The deal involves an upfront cash payment of $925 million, followed by a potential $300 million commercial milestone payment.
The deal will strengthen Stryker’s portfolio of smart technologies in its joint replacement business and provide products that help physicians make data-driven decisions.
For medical device manufacturers, the American Invents Act created several challenges related to patent marking.
A look at IP litigation in 2019 and the year ahead, and some advice on how medical device companies can safeguard their intellectual property.
The deal is expected to close in the second half of 2020, but one analyst expects the transaction will raise antitrust issues in the United States.
Overall activity in deals jumped 11% in North America.
The deal boosts 3M’s capabilities in advanced and surgical wound care.
The strategic acquisitions expand the company’s structural heart disease technologies.
The deal will help J&J speed up its entry into the robotics market.